Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLoans - NetMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Creative Medical Technology Holdings (CELZ) Receivables (2017 - 2021)

Creative Medical Technology Holdings (CELZ) has disclosed Receivables for 5 consecutive years, with $2485.0 as the latest value for Q4 2021.

  • Quarterly Receivables changed N/A to $2485.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $2485.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $2485.0 for FY2021, N/A changed from the prior year.
  • Receivables for Q4 2021 was $2485.0 at Creative Medical Technology Holdings, up from $1400.0 in the prior quarter.
  • The five-year high for Receivables was $24500.0 in Q3 2019, with the low at $163.0 in Q1 2019.
  • Average Receivables over 5 years is $7195.8, with a median of $5200.5 recorded in 2017.
  • The sharpest move saw Receivables crashed 98.3% in 2019, then surged 5053.37% in 2020.
  • Over 5 years, Receivables stood at $4801.0 in 2017, then skyrocketed by 99.96% to $9600.0 in 2018, then plummeted by 41.67% to $5600.0 in 2019, then tumbled by 75.0% to $1400.0 in 2020, then soared by 77.5% to $2485.0 in 2021.
  • According to Business Quant data, Receivables over the past three periods came in at $2485.0, $1400.0, and $8400.0 for Q4 2021, Q2 2020, and Q1 2020 respectively.